Pagina de pornireALKS • NASDAQ
add
Alkermes
Închidere anterioară
31,75 $
Intervalul de astăzi
31,78 $ - 33,52 $
Interval anual
25,17 $ - 36,45 $
Capitalizare bursieră
5,52 mld. USD
Volum mediu
1,84 mil.
Raport P/E
16,53
Randamentul dividendelor
-
Bursă principală
NASDAQ
Despre
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Director executiv
Înființare
1987
Site
Angajați
1.800
